Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1998 Nov;79(5):423–426. doi: 10.1136/adc.79.5.423

Parental view of epilepsy in Angelman syndrome: a questionnaire study

M Ruggieri 1, M McShane 1
PMCID: PMC1717750  PMID: 10193256

Abstract

PURPOSE—To explore parents' opinions and concerns about seizures, anticonvulsants, and the effect of treatment in children with Angelman syndrome.
DESIGN—A postal questionnaire was sent to members of one of the UK lay groups for Angelman syndrome (ASSERT) who had a child affected by Angelman syndrome. The questionnaire requested general medical information and information about the epilepsy, its treatment, and treatment responses.
RESULTS—One hundred and fifty questionnaires were sent out with an ASSERT routine mailing and 78 completed questionnaires were returned. Forty three patients were boys and 35 were girls; ages ranged from 1.7 to 25 years (mean 7.5 years). The overall general clinical and cytogenetic data were mostly consistent with previous reports. Epilepsy was reported in 68 children, most of whom had a detectable cytogenetic deletion. The most common seizure types reported by the families were absence seizures, tonic clonic seizures, drop attacks, and myoclonic seizures; in four patients only febrile seizures occurred. The age at onset of the seizures was < 2 years in more than half of the patients. Anti-epileptic drug treatment with valproate (VPA), clonazepam (CZP), and lamotrigine (LTG) as monotherapy or a combination of VPA and CZP or VPA and LTG was more often viewed favourably and considered effective with fewer side effects on the child's behaviour and alertness, versus more frequent adverse effects and increased frequency and severity of seizures with carbamazepine (CBZ) and vigabatrin (VGB) in monotherapy or in combination with other anti-epileptic drugs. Seizures did tend to improve with age but were still present and disabling at older ages.
CONCLUSIONS—This is the first study to record parents' opinions about seizures, anti-epileptic drugs, and treatment responses in children with Angelman syndrome, and it is one of the largest series on epilepsy and Angelman syndrome to be reported to date.



Full Text

The Full Text of this article is available as a PDF (91.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjerre I., Fagher B., Ryding E., Rosén I. The Angelman or "happy puppet" syndrome. Clinical and electroencephalographic features and cerebral blood flow. Acta Paediatr Scand. 1984 May;73(3):398–402. doi: 10.1111/j.1651-2227.1994.tb17755.x. [DOI] [PubMed] [Google Scholar]
  2. Bottani A., Robinson W. P., DeLozier-Blanchet C. D., Engel E., Morris M. A., Schmitt B., Thun-Hohenstein L., Schinzel A. Angelman syndrome due to paternal uniparental disomy of chromosome 15: a milder phenotype? Am J Med Genet. 1994 May 15;51(1):35–40. doi: 10.1002/ajmg.1320510109. [DOI] [PubMed] [Google Scholar]
  3. Boyd S. G., Harden A., Patton M. A. The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr. 1988 Jun;147(5):508–513. doi: 10.1007/BF00441976. [DOI] [PubMed] [Google Scholar]
  4. Buntinx I. M., Hennekam R. C., Brouwer O. F., Stroink H., Beuten J., Mangelschots K., Fryns J. P. Clinical profile of Angelman syndrome at different ages. Am J Med Genet. 1995 Mar 27;56(2):176–183. doi: 10.1002/ajmg.1320560213. [DOI] [PubMed] [Google Scholar]
  5. Clayton-Smith J. Angelman's syndrome. Arch Dis Child. 1992 Jul;67(7):889–890. doi: 10.1136/adc.67.7.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clayton-Smith J. Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals. Am J Med Genet. 1993 Apr 1;46(1):12–15. doi: 10.1002/ajmg.1320460105. [DOI] [PubMed] [Google Scholar]
  7. Ganji S., Duncan M. C. Angelman's (happy puppet) syndrome: clinical, CT scan and serial electroencephalographic study. Clin Electroencephalogr. 1989 Apr;20(2):128–140. doi: 10.1177/155005948902000210. [DOI] [PubMed] [Google Scholar]
  8. Guerrini R., De Lorey T. M., Bonanni P., Moncla A., Dravet C., Suisse G., Livet M. O., Bureau M., Malzac P., Genton P. Cortical myoclonus in Angelman syndrome. Ann Neurol. 1996 Jul;40(1):39–48. doi: 10.1002/ana.410400109. [DOI] [PubMed] [Google Scholar]
  9. Hou J. W., Wang P. J., Wang T. R. Angelman syndrome assessed by neurological and molecular cytogenetic investigations. Pediatr Neurol. 1997 Jan;16(1):17–22. doi: 10.1016/s0887-8994(96)00264-0. [DOI] [PubMed] [Google Scholar]
  10. Kishino T., Lalande M., Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997 Jan;15(1):70–73. doi: 10.1038/ng0197-70. [DOI] [PubMed] [Google Scholar]
  11. Kyllerman M. On the prevalence of Angelman syndrome. Am J Med Genet. 1995 Nov 20;59(3):405–404. doi: 10.1002/ajmg.1320590331. [DOI] [PubMed] [Google Scholar]
  12. Laan L. A., Renier W. O., Arts W. F., Buntinx I. M., vd Burgt I. J., Stroink H., Beuten J., Zwinderman K. H., van Dijk J. G., Brouwer O. F. Evolution of epilepsy and EEG findings in Angelman syndrome. Epilepsia. 1997 Feb;38(2):195–199. doi: 10.1111/j.1528-1157.1997.tb01097.x. [DOI] [PubMed] [Google Scholar]
  13. Laan L. A., den Boer A. T., Hennekam R. C., Renier W. O., Brouwer O. F. Angelman syndrome in adulthood. Am J Med Genet. 1996 Dec 18;66(3):356–360. doi: 10.1002/(SICI)1096-8628(19961218)66:3<356::AID-AJMG21>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  14. Leitner R. P., Smith A. An Angelman syndrome clinic: report on 24 patients. J Paediatr Child Health. 1996 Apr;32(2):94–98. doi: 10.1111/j.1440-1754.1996.tb00902.x. [DOI] [PubMed] [Google Scholar]
  15. Matsumoto A., Kumagai T., Miura K., Miyazaki S., Hayakawa C., Yamanaka T. Epilepsy in Angelman syndrome associated with chromosome 15q deletion. Epilepsia. 1992 Nov-Dec;33(6):1083–1090. doi: 10.1111/j.1528-1157.1992.tb01763.x. [DOI] [PubMed] [Google Scholar]
  16. Matsuura T., Sutcliffe J. S., Fang P., Galjaard R. J., Jiang Y. H., Benton C. S., Rommens J. M., Beaudet A. L. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet. 1997 Jan;15(1):74–77. doi: 10.1038/ng0197-74. [DOI] [PubMed] [Google Scholar]
  17. Sandanam T., Beange H., Robson L., Woolnough H., Buchholz T., Smith A. Manifestations in institutionalised adults with Angelman syndrome due to deletion. Am J Med Genet. 1997 Jun 27;70(4):415–420. doi: 10.1002/(sici)1096-8628(19970627)70:4<415::aid-ajmg16>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  18. Smith A., Wiles C., Haan E., McGill J., Wallace G., Dixon J., Selby R., Colley A., Marks R., Trent R. J. Clinical features in 27 patients with Angelman syndrome resulting from DNA deletion. J Med Genet. 1996 Feb;33(2):107–112. doi: 10.1136/jmg.33.2.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Steffenburg S., Gillberg C. L., Steffenburg U., Kyllerman M. Autism in Angelman syndrome: a population-based study. Pediatr Neurol. 1996 Feb;14(2):131–136. doi: 10.1016/0887-8994(96)00011-2. [DOI] [PubMed] [Google Scholar]
  20. Sugimoto T., Yasuhara A., Ohta T., Nishida N., Saitoh S., Hamabe J., Niikawa N. Angelman syndrome in three siblings: characteristic epileptic seizures and EEG abnormalities. Epilepsia. 1992 Nov-Dec;33(6):1078–1082. doi: 10.1111/j.1528-1157.1992.tb01762.x. [DOI] [PubMed] [Google Scholar]
  21. Van Lierde A., Atza M. G., Giardino D., Viani F. Angelman's syndrome in the first year of life. Dev Med Child Neurol. 1990 Nov;32(11):1011–1016. doi: 10.1111/j.1469-8749.1990.tb08125.x. [DOI] [PubMed] [Google Scholar]
  22. Viani F., Romeo A., Viri M., Mastrangelo M., Lalatta F., Selicorni A., Gobbi G., Lanzi G., Bettio D., Briscioli V. Seizure and EEG patterns in Angelman's syndrome. J Child Neurol. 1995 Nov;10(6):467–471. doi: 10.1177/088307389501000609. [DOI] [PubMed] [Google Scholar]
  23. Williams C. A., Angelman H., Clayton-Smith J., Driscoll D. J., Hendrickson J. E., Knoll J. H., Magenis R. E., Schinzel A., Wagstaff J., Whidden E. M. Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet. 1995 Mar 27;56(2):237–238. doi: 10.1002/ajmg.1320560224. [DOI] [PubMed] [Google Scholar]
  24. Williams C. A., Zori R. T., Hendrickson J., Stalker H., Marum T., Whidden E., Driscoll D. J. Angelman syndrome. Curr Probl Pediatr. 1995 Aug;25(7):216–231. doi: 10.1016/s0045-9380(06)80036-8. [DOI] [PubMed] [Google Scholar]
  25. Yamada K. A., Volpe J. J. Angelman's syndrome in infancy. Dev Med Child Neurol. 1990 Nov;32(11):1005–1011. doi: 10.1111/j.1469-8749.1990.tb08124.x. [DOI] [PubMed] [Google Scholar]
  26. Zori R. T., Hendrickson J., Woolven S., Whidden E. M., Gray B., Williams C. A. Angelman syndrome: clinical profile. J Child Neurol. 1992 Jul;7(3):270–280. doi: 10.1177/088307389200700307. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES